Treatment of severe rash caused by crizotinib with both traditional Chinese medicine and Western medicine
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference29 articles.
1. Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009
2. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010
3. ROS1 rearrangements define a unique molecular class of lung cancers;Bergethon;J Clin Oncol,2012
4. Preclinical rationale for use of the clinically available multi-targeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer;Yasuda;J Thorac Oncol,2012
5. A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients;Dikopf;Expert Opin Drug Saf,2015
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress in the treatment of lung adenocarcinoma by integrated traditional Chinese and Western medicine;Frontiers in Medicine;2024-01-08
2. Clinical Experience of External Application of Clearing Heat and Removing Dampness in Relieving Grade 2 to 3 Rash Caused by Programed Cell Death Protein 1 (PD-1)/Programed Cell Death Ligand 1 (PD-L1) Inhibitors: A Single-Center Retrospective Study;Integrative Cancer Therapies;2024-01
3. Photosensitivity associated with anaplastic lymphoma kinase inhibitors: A review of postmarketing cases reported to FDA and published in the literature;Photodermatology, Photoimmunology & Photomedicine;2022-08-30
4. Review: Natural products isolated from Portulaca oleracea (purslane, Ma-Chi-Xian): Focus on oleraciamides and oleracones;Nusantara Bioscience;2021-11-09
5. Experimental and clinical studies on the effects of Portulaca oleracea L. and its constituents on respiratory, allergic, and immunologic disorders, a review;Phytotherapy Research;2021-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3